EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SP1‐activated USP27X‐AS1 promotes hepatocellular carcinoma progression via USP7‐mediated AKT stabilisation

Chen Su, Haoquan Zhang, Jie Mo, Zhibin Liao, Bixiang Zhang, Peng Zhu iD

Clinical and Translational Medicine · 2024

DOI: 10.1002/ctm2.1563 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Medicine, 2024. Verfasst von Chen Su und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People's Republic of Ch…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, RNA, Long Noncoding. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hepatocellular carcinoma (HCC) continues to pose a significant threat to patient survival. Emerging evidence underscores the pivotal involvement of long non‐coding RNAs (lncRNAs) in the cancer process. Nevertheless, our understanding of the roles and processes of lncRNAs in HCC remains limited.

Methods

The expression level of USP27X‐AS1 was assessed in an HCC patient cohort through a combination of bioinformatics analysis and qRT‐PCR. Subsequent biological experiments were conducted to delve into the functional aspects of USP27X‐AS1. Additional molecular biology techniques, including RNA pulldown and RNA immunoprecipitation (RIP), were employed to elucidate the potential mechanisms involving USP27X‐AS1 in HCC. Finally, CUT–RUN assay and other investigations were carried out to determine the factors contributing to the heightened expression of USP27X‐AS1 in HCC.

Results

High expression of the novel oncogene USP27X‐AS1 predicted poor prognosis in HCC patients. Further investigation confirmed that USP27X‐AS1 promoted the proliferation and metastasis of HCC by enabling USP7 to interact with AKT, which reduced level of AKT poly‐ubiquitylation and enhanced AKT protein stability, which improves protein stabilisation of AKT and promotes the progression of HCC. Moreover, we also revealed that SP1 binds to USP27X‐AS1 promoter to activate its transcription.

Conclusions

Novel oncogenic lncRNA USP27X‐AS1 promoted HCC progression via recruiting USP7 to deubiquitinate AKT. SP1 transcriptionally activated USP27X‐AS1 expression. These findings shed light on HCC and pointed to USP27X‐AS1 as a potential predictive biomarker and treatment target for the malignancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsRNA, Long NoncodingHumansCell Line, TumorCell ProliferationProto-Oncogene Proteins c-aktUbiquitin-Specific Peptidase 7Ubiquitin-Specific ProteasesSp1 Transcription Factor

Stichwörter der Autor:innen

AKTUSP27X-AS1USP7hepatocellular carcinomaubiquitination

Substanzen

Proto-Oncogene Proteins c-aktRNA, Long NoncodingUbiquitin-Specific Peptidase 7USP7 protein, humanUSP27X protein, humanUbiquitin-Specific ProteasesSP1 protein, humanSp1 Transcription Factor

Autor:innen und Institutionen

  • Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People's Republic of China.
  • Hubei Key Laboratory of Hepato-Pancreato-Biliary Diseases, Wuhan, Hubei, People's Republic of China.
  • Key Laboratory of Organ Transplantation, Ministry of Education, Wuhan, Hubei, People's Republic of China.
  • Key Laboratory of Organ Transplantation, National Health Commission, Wuhan, Hubei, People's Republic of China.
  • Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences, Wuhan, Hubei, People's Republic of China.

ORCID-Profile: Peng Zhu

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Su, C., Zhang, H., Mo, J., Liao, Z., Zhang, B., & Zhu, P. (2024). SP1‐activated USP27X‐AS1 promotes hepatocellular carcinoma progression via USP7‐mediated AKT stabilisation. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.1563

Vancouver

Su C, Zhang H, Mo J, Liao Z, Zhang B, Zhu P. SP1‐activated USP27X‐AS1 promotes hepatocellular carcinoma progression via USP7‐mediated AKT stabilisation. Clinical and Translational Medicine. 2024. doi:10.1002/ctm2.1563

BibTeX
@article{Su2024,
  author = {Su, Chen and Zhang, Haoquan and Mo, Jie and Liao, Zhibin and Zhang, Bixiang and Zhu, Peng},
  title = {SP1‐activated USP27X‐AS1 promotes hepatocellular carcinoma progression via USP7‐mediated AKT stabilisation},
  journal = {Clinical and Translational Medicine},
  year = {2024},
  doi = {10.1002/ctm2.1563}
}
Kostenlos starten →